# Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?

> **NCT05656300** · — · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DIAGNOSTIC_TEST:** MRI scan using USPIO particles

## Key facts

- **NCT ID:** NCT05656300
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2022-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05656300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05656300, "Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05656300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*